Morningstar Aandelenrapport

Eli Lilly and Co LLY

Marges (% van omzet)
20192020202120222023
Inkomsten100,00%100,00%100,00%100,00%100,00%
Kosten van inkomsten21,15%22,34%25,82%23,23%20,75%
Brutomarge 78,85%77,66%74,18%76,77%79,25%
SG&A26,90%23,92%21,69%21,26%20,34%
Research and development25,07%24,80%24,81%25,19%27,29%
Exploitatiemarge 26,88%28,94%27,68%30,32%31,61%
Net Int, Inc and Other50,47%58,40%49,41%54,17%50,82%
EBT-marge23,59%29,46%21,74%23,85%19,21%
Winstgevendheid
20192020202120222023
Belastingtarief2,81%4,22%2,03%1,97%3,85%
Nettomarge37,27%25,24%19,71%21,88%15,36%
Rendement op activa 20,0014,4211,7012,719,23
Financiële leverage15,078,275,444,655,94
Rendement op eigen vermogen 133,78150,1876,3563,6348,93
© Copyright 2024 Morningstar, Inc. Alle rechten voorbehouden.

Voorwaarden        Privacybeleid        Cookie Settings        Beleidsdocumenten